Genetically engineered cells that overproduce ACE2, the receptor the novel coronavirus uses to enter cells, neutralize infection in vitro and mop up inflammatory cytokines in mice.

The authors of a new analysis conclude that tens of thousands of lives could have been saved with a more coordinated national response to the coronavirus.

The company voluntarily paused its studies, including one in Phase 3, after an unexplained illness in a patient.

We asked experts for measures people can take that may help boost defenses against COVID-19 and other respiratory diseases.

From hospitals and college campuses to remote villages in French Guiana, scientists have pit the two approaches against one other. See which one comes out ahead.

Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.

While sick with COVID-19, President Trump is taking an antacid. Doctors have been exploring whether these medicines can treat SARS-CoV-2 infections, and the results are mixed.

The President was hospitalized on Friday evening and has been receiving an aggressive treatment of experimental and standard drugs.

Experts will discuss their research on SARS-CoV-2 antibody persistence and immune memory in recovered COVID-19 patients and the implications for protective immunity.